Carlito, Ephraim D.
HRN: 16-82-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/31/2022
01/06/2023
IV
365mg
Q6hours
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes